Advertisement

Picture Demy-Colton BioFuture 2024 NYC 3 Biotech Breakthroughs 650x100px
Person › Details

Matthew (Matt) Kapusta (Uniqure N.V. (Nasdaq: QURE))

Kapusta, Matthew (Matt) (Uniqure 201612– CEO before interim CEO before CFO before AngioDynamics + Smith & Nephew)

 

Organisation Organisation Uniqure N.V. (Nasdaq: QURE)
  Group Uniqure (Group)
Products Product Glybera®
  Product 2 Hemgenix®
     

   
Record changed: 2023-05-18

Advertisement

Picture Demy-Colton BioFuture 2024 NYC 3 Healthcare Revolution 650x200px


More documents for Matthew (Matt) Kapusta


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px




» top